Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Anthony Gordon 'does not threaten' Bayern Munich's starting XI but his proposed transfer to Bavaria from Newcastle United sums up the 'problem' facing the Magpies in this summer's transfer window and ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Abstract: The Subset Sum problem is a classical NP-complete problem with applications in resource allocation, cryptography, and combinatorial optimization. Conventional backtracking methods search the ...

Over the last few days, UpScrolled went from a relatively unknown app to the top of the App Store, as users flocked away from TikTok. Here are the details. A few days ago, the years-long saga ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Birgitta Böckeler, Distinguished Engineer at ...

What Is Ali Velshi Talking About? L.A. Mayor Karen Bass’s Incompetence Is Only the Start of Her Problems The New Politics of Resentment Uncertainty at Shangri-La: Will America’s Indo-Pacific Allies ...

One reason Recursion Pharmaceuticals could become a big deal is that its goal is to usher a paradigm shift into the pharmaceutical industry. Even with impressive technological progress over the past ...